# OnCo record eribulin-payload (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/eribulin-payload/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "eribulin-payload" ;
  schema:name "Eribulin as an antibody-conjugate payload"@en ;
  schema:alternateName "ecteribulin payload"@en, "MORAb-202 payload"@en, "halichondrin-derived payloads"@en ;
  schema:description "Eribulin is a drug that disrupts the scaffolding needed for cell division. Linking it to an antibody changes how it is delivered and needs separate evidence from eribulin given on its own."@en ;
  schema:url <https://onco.cc/terms/eribulin-payload/> ;
  schema:dateModified "2026-11-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1111/cas.14898> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:drugs <https://onco.cc/drugs/eribulin/>, <https://onco.cc/drugs/farletuzumab-ecteribulin/> ;
  onco:terms <https://onco.cc/terms/payload/>, <https://onco.cc/terms/tubulin-inhibitor-payloads/> .
